Advair Diskus Asthma Inhalers Being RecalledNov 19, 2004 | www.cm-life.com Advair Diskus 100/50 mcg strength 60 dose dry powder inhalers for a defect that occurred during manufacturing.
The defect may cause a person using the inhaler to not receive the proper dose of medication, officials said.
The inhalers were manufactured by GlaxoSmithKline at a Zebulon, N.C. facility between March 17 and May of this year. They were distributed in the United States from July 1 until Oct. 6, the company announced this week.
GlaxoSmithKline reports that approximately 150 inhalers out of the 410,000 in 25 lots will not work properly.
Sarah Campbell, director of University Health Services, said the chance of having a defective inhaler is a fraction of a percent.
“The risk is very low for the two to three dozen students from CMU that have purchased these inhalers from us,” Campbell said.
Although the risk is very low, Campbell wants each student possessing these inhalers to check the lot number on the inhaler to be safe.
“The devices are clearly labeled so it should be pretty easy to check,” Campbell said.
Campbell said any student with a defective inhaler should cease using the device and bring it to Health Services, Foust Hall 249, for a free replacement.
“They don’t have to be alarmed by it,” Campbell said. “They should still use it because even though it may not be giving proper dosage it could be giving them some.”
The Advair Diskus inhalers are used for long term asthma, not the more severe, acute forms of asthma, Campbell said.
Craig Buys, University Health Services pharmacist, said he was surprised the recall wasn’t as large as some people first expected.
“When we first heard that there was going to be a withdrawal we thought it was going to be a lot,” Buys said.
Affected Advair Diskus lots